載入...
P04.12 The preclinical efficacy study using mesenchymal stem cells expressing TRAIL & CD for glioblastoma.
BACKGROUND: Our previous study using mesenchymal stem cells (MSCs) as delivery vehicles for tumor necrosis factor-related apoptosis inducing ligand (TRAIL) showed an anti-tumor effect in vitro and in vivo for glioblastoma. However, because most malignant glioma cells exhibit TRAIL resistance, we nee...
Na minha lista:
| 發表在: | Neuro Oncol |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6144671/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.246 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|